Neuroprotective effect of masitinib in rats with postischemic stroke

This study evaluated the therapeutic potential of masitinib, an oral tyrosine kinase inhibitor with activity against c-Kit and platelet-derived growth factor receptors (PDGFR), to reduce ischemic brain area and neurological deficit. Using a well-established filament model of ischemic stroke in rats,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Naunyn Schmiedebergs Arch Pharmacol
Päätekijät: Kocic, Ivan, Kowianski, Przemyslaw, Rusiecka, Izabela, Lietzau, Grazyna, Mansfield, Colin, Moussy, Alain, Hermine, Olivier, Dubreuil, Patrice
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4284372/
https://ncbi.nlm.nih.gov/pubmed/25344204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-014-1061-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia